Why a Buyout Deal May Not Be in the Cards for Acadia Post author:Sam Post published:November 27, 2017 Post category:BioPharma A look at why a potential buyout of Acadia might not be as likely as some have suggested. Source: BioSpace You Might Also Like Recipharm to End Operations at Two Swedish Facilities, 225 Employees Affected November 8, 2017 Sources Reveal Tesaro is Unlikely to Find a Buyer July 13, 2017 Eli Lilly Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs July 24, 2017